Initial treatment commonly includes the use of cholinesterase inhibitors, which increase muscle strength by preventing the normal breakdown of the neurotransmitter acetylcholine.
Therefore, this risk must be taken into consideration by surgeons, anesthesiologists, dentists, or other health care workers when making decisions concerning potential surgery and use of anesthetics.
Symptoms often become progressively worse during periods of activity, but they improve after resting. Some cases of myasthenia gravis may go into remission—either temporarily or permanently—and muscle weakness may disappear completely so that medications can be discontinued.
Exercise participation should be encouraged with frequent rest. Immunosuppressive drugs. A neurologist may need to confirm the diagnosis.
Because weakness is a common symptom of many other disorders, the diagnosis of myasthenia gravis is often missed or delayed sometimes up to two years in people who experience mild weakness or in those individuals whose weakness is restricted to only a few muscles.
Studies are under way to find more effective treatments for MG. Plasmapheresis involves depleting the body of blood plasma without depleting the body of its blood cells, in order to remove the unwanted antibodies.
The areas of contact between nerve endings and skeletal muscle fibers are known as neuromuscular junctions. In those with autoimmune myasthenia gravis associated with thymoma, recommended treatment is surgical removal of the tumor and the remaining thymus thymectomy.